Cell Pathways in Aptosyn agreements

CLPA signed agreements with Innovex, Livingston Healthcare, and Lash Group for U.S. sales and distribution of its Aptosyn exisulind oral medication to treat familial adenomatous polyposis (FAP). Innov...